To define better the chromosomal profile of atypical chronic karyotype may in fact carry chromosomally abnormal clones lymphocytic leukemia (aCLL), cytogenetic and interphase cytoescaping detection at metaphase analysis due to their low genetic studies were performed in 43 cases, using mitogenmitotic index. a relatively poor prognosis may be associated with aCLL.
significance in lymphoid neoplasias, have been found to be confirmed the results of chromosome banding analysis and frequently associated with cytologically atypical CLL. 11, 12 showed that six patients with normal karyotype or no mitosis Thus, chromosome anomalies may contribute towards a in fact had concomitant ؉12 and 13q14 deletion in four cases refinement of the classification of CLL 13 and may potentially and isolated ؉12 or 13q14 deletion in one case each, with a provide a biologic argument supporting the observation that resultant 76% overall incidence of cytogenetic abnormalities.
a relatively poor prognosis may be associated with aCLL.
The presence of ؉12, 13q14 deletions, 11q, and 6q21-q23 anomalies in 19 cases was associated with a 2-month median inter-
To define better the cytogenetic profile of aCLL, this study val between diagnosis and start of treatment, as compared with of 43 cases was carried out combining conventional chromoa 24-month median interval in 14 cases with normal karyotype some analysis (CCA) and FISH, using probes detecting the two or non-recurrent chromosome changes (P ‫؍‬ 0.003). We conmost frequent anomalies in CLL, ie +12 and del(13q14).
clude that aCLL is characterized by a relatively high incidence of chromosome anomalies, with recurrent chromosome changes, involving chromosomes 12, 13q14, 6q21q23, 11q,
Materials and methods
and, possibly, 4q. The presence of complex karyotypes, with concomitant abnormalities of 13q, ؉12, 6q, 11q, suggests that lymphocytes and/or prolymphocytes (see below) among approximately 260 B-CLLs, seen at our Institution over a 9-year period.
Introduction
Diagnoses were made in all cases according to standard clinical, cytologic and immunologic criteria. Histologic studThe importance of cytogenetics of B cell chronic lymphocytic ies were performed for diagnostic purposes in 27 cases (bone leukemia (CLL) has been highlighted over the past 10 years biopsy in 19 cases and superficial lymph node biopsy in eight in a number of studies, reviewed by Juliusson and Gahrton, 1 cases). Transformation of aCLL into prolymphocytic leukemia documenting that some chromosome changes, such as tri-(PLL) was not an exclusion criteria, whereas those patients somy 12, del (11q) or 14q anomalies are associated with therpresenting with 'de novo' PLL were not considered in this apy-demanding disease and, ultimately, with shorter survival. 2 study. More recently, introduction of fluorescence in situ hybridizStaging procedures according to Rai's classification ation (FISH), detecting specific chromosome anomalies in included physical examination, a routine laboratory profile, interphase cells, has shown that some patients with normal chest X-ray film and abdomen ultrasonography. 6 as CLL in the presence of less than 10% LL and PL, as aCLL when PL Detection of t(11;14)(q13;q32): All cases were tested with a BCL1 yeast artificial chromosome (YAC) probe, spanning a and LL comprised between 10% and 55% of all lymphocytes and as PLL when more than 55% PL were present on PB 390 kb area in the BCL1 locus, including the major translocation cluster, as previously reported. 4 The presence of smears.
Immunophenotyping was performed as routine diagnostic trisomy/monosomy 11 was excluded using a chromosome 11-specific pericentromeric probe (Oncor). work-up. Cytofluorimetric study of PB cells, gating primarily on lymphocytes was performed on a FACScan analyser (Becton Dickinson, San Jose, CA, USA). Commercially available reagents detecting the following surface markers were Hybridization conditions, signal amplification and detection: Cells for FISH studies were derived from the same used: B cell lineage: CD10, CD19, CD22, CD23; T cell lineage: CD2, CD3, CD5. Expression of the CD11c and CD25 samples that had been used for cytogenetic analysis. Usually, samples with more than 90% clonal CD5 + /CD19 + cells were antigens was also assessed, as well as reactivity with the monoclonal antibody FMC7 (Silenius Lab, Hawthorn, Australia).
obtained by separation over Ficoll gradient. Ten normal control samples were tested in order to calculate the cut-off point Double labeling with monoclonal antibodies detecting the CD19 and CD5 antigens was performed. The cut-off point for for positivity using the chromosome-12-specific and 13q14 probe. positivity was set at 30% cells showing fluorescence above controls. Surface immunoglobulins (slg) were detected using
The slides were incubated for 60 min with RNAse (100 g/ml; Boehringer Mannheim, Germany), washed twice rabbit antihuman antibodies against Ig heavy and light chain. sIg expression of the leukemic cells was interpreted as 'weak' in 2 × SSC, dehydrated in ethanol alcohol series (75, 85 and 100%) and air dried. The denaturation was performed by if the mean intensity of fluorescence was Ͻ256 and 'bright' if Ͼ256 (logarithmic acquisition, 0-1024 channel range).
immersion of the slides in a 70% formamide/2 × SSC solution at 70°C for 2 min and dehydrated in the same alcohol series. The 13q14 cosmid probe and the chromosome 12-specific pericentromeric probe were biotinylated with a BioNick Cytogenetic studies
Labelling System Kit (GIBCO BRL, Gaithersburg, MD, USA) according to the manufacturer's instructions and precipitated Cytogenetic techniques employed in our laboratory were described previously. 14 with Human Cot-1 DNA (GIBCO BRL) to suppress non-specific signals due to repetitive sequences. The DNA probe was After separation over a Ficoll gradient, PB lymphocytes were cultured in RPMI 1640 with 10% fetal calf serum. Two resuspended in a hybridization mixture with 50% formamide, 10% dextran sulphate in 12.5 × SSPE, 5 × Denhardt's solution. or more of the following mitogens were employed: phorbol myristate acetate (PMA) (50 ng/ml) lipopolysaccaride (LPS)
Sixty microliters of the mixture were added to each slide and incubated overnight. Post-hybridization washes included 50% (0.1 mg/ml); phytohemagglutinin (PHA) (0.1 mg/ml), pokeweed mitogen (0.1 mg/ml).
formamide/2 × SSC, 1 × SSC and 0.1 × SSC baths at 45°C each, with intermittent agitation. Detection was performed Karyotypic analyses were performed within the first 2 years of diagnosis in all patients. At least 10 mitoses were karyowith alternating layers of fluoresceinated avidin (FITC-avidin) and biotinylated goat anti-avidin (5 ng/l; Vector Laboratories, typed and chromosome anomalies were described according to the ISCN. 15 Burlingame, CA, USA), until two layers of avidin were applied; each treatment was followed by 2 × SSC washes 2 min each. Rhodamine-conjugated monoclonal antibodies (red) were employed for the detection of digoxigenin-labeled FISH studies probes, using a commercially available detection kit (Oncor). A DAPI or propidium iodide fluorescent antifade solution was Detection of trisomy 12:
The presence of trisomy 12 was assessed by using a chromosome 12-specific pericentromeric applied on to the slides as counter-stain, as appropriate. The evaluation was performed on more than 200 interphase cells probe (Oncor, Gaithersburg, MD, USA). Experimental conditions, according to the manufacturer's instructions, were with well-delineated signals on a Leitz Wetzlar fluorescence equipped microscope; the FISH experiment was repeated employed as previously described. 16 when more than 20% cells showed no signal. Images for illustration purposes were captured using a cooled charge-coupled device (CCD) camera (Princeton Instruments, Princeton, NJ, Detection of del 13q:
Deletions involving the 13q14 region in interphase cells were studied with the biotin-labeled USA). C21 cosmid. The C21 cosmid clone was isolated by PCR screening, with GCT16C05 microsatellite specific primers, of a cosmid library constructed from CEPHB YAC clone 745E3.
Results The GCT16C05 marker is located between Rb and the D13S25 marker and is homozygously or hemizygously lost in Forty-three patients, corresponding to 16% of all CLLs seen at our Institution during the study period, fulfilled the above crimore than 40% of B-CLL. 17 To prevent false positive results, dual color hybridization was performed by adding a digoxiteria for the diagnosis of aCLL. Fourteen 'atypical CLLs' with BCL1 translocation, deriving from the t(11;14)(q13;q32), genin-labeled probe (control probe), recognizing DNA sequences at the telomeres of chromosome 13q (Oncor Figure 1) . Globally, pro-11, 22, 27, respectively), aberrations of 3q, 6q, 7q and 17p lymphocytes with prominent central nucleoli were seen in three cases each (Nos 4, 14, 23; Nos 10, 18, 19; Nos 15, infrequently, these cells representing 3% of all lymphocytes 18, 22; Nos 7, 14, 18, respectively). Two cases each had 3p (median value in 43 cases, range 0-50%). Cells with indented translocations and structural abnormalities of 4q (one interor irregular nuclear outlines were only observed occasionally.
stitial deletion and one 4q+ chromosome, with distinct In 30 cases, an admixture of small lymphocytes and of larger breakpoints) (Nos 4, 7 and 20, 21). lymphocytes with round nuclei and Ͻ10% prolymphocytes Possible recurrent 'primary' anomalies (ie those aberrations was observed, whereas in 13 cases Ͼ10% prolymphocytes present in all abnormal karyotypes in a given patient) were: were seen in PB smears, corresponding to the CLL/PL category total or partial trisomy 12 in nine cases, one of which also had of the FAB classification. 6 These 43 patients will be globally a 13q− chromosome in all abnormal metaphases (Nos 1-9); referred to as aCLL. In 19 cases, bone biopsies showed a pre13q abnormalities in five cases (Nos 10-14), 11q abnormalities vailing small lymphocyte infiltrate, with a minority of larger in three cases (Nos 15-17) 6q21-q23 abnormalities in two lymphoid cells or prolymphocytes. The infiltration pattern was cases, one of which also had +12 in all abnormal metaphases. nodular in two cases, interstitial in seven cases, mixed in three Aberrations of 4q were seen in two cases, showing different cases and diffuse in seven cases. In eight cases, histologic finbreakpoints (see Table 1 ). The following associations were dings on lymph node specimen showed a diffuse infiltrate noted (see Table 3 ): trisomy 12 with 13q14 abnormalities in consisting of small lymphocytes, intermingled with some three cases (Nos 4, 7 and 9), one of which also had an 11q paraimmunoblasts and prolymphocytes, frequently forming abnormality; 13q14 aberrations with a 6q abnormality in one pseudoproliferation centres.
case 13q14 C21 cosmid, whereas 3.8% and 3.1% interphase cells 24 months, range 0-72+ months) (P = 0.0031, log-rank test).
(mean values) had none or one signal, respectively. The cutoff point for positivity was therefore set at 3% for trisomy 12
Cytogenetic findings and at 10% for 13q14 deletions.
Karyotypes are described in Seventeen of 43 patients in this series were shown to carry deletions of the 13q14 DNA target region chromosome 13, had a 13q14 deletion as detected by FISH. Interphase cytogenetic analysis could detect deletions at chromosome abnormalities than with normal karyotype (11/20 vs 0/5, P = 0.027).
22
13q14 in three cases with normal karyotypes (Nos 28-30) and in two cases without analyzable mitoses (Nos 34 and 36). The evolutive phases of CLL, including prolymphocytoid transformation, were noted to be associated with a high inciEight cases (Nos 4, 7, 9, 18, 28, 29, 34, 36) had both 13q14 deletions and +12 in interphase cells.
dence of karyotype anomalies, including +12 and a 14q+ chromosome, as early as 1984. 23 Later on, after the FAB group proposed objective criteria for the distinction of typical CLL from allied disorders, convincing evidence was provided that t(11;14)(q13;q32):
Two signals in Ͼ95% interphase cells were detected by FISH in all 43 cases, using the BCL1 YAC trisomy 12 may characterize a subset of CLL with atypical morphologic features 21 and few patients were reported with probe. No patient was found with monosomy 11. aCLL and 14q translocations, 22 deletions (6q) and del (11q), as summarized in Table 4 .
The percentage of patients with chromosome changes was Discussion higher in this series (62.8%) than in 433 patients with cytologically unselected CLLs, collected in a multicentre study by In this study, a systematic approach to the definition of the cytogenetic profile of aCLL was used, with conventional chroJuliusson and co-workers, 2 who found a 50% incidence of clonal abnormalities. In this report, the percentage of abnormosome analysis and detection by FISH of the two most frequent changes in CLL, ie +12 and 13q14 deletions. Stimumal cases was even higher when considering that FISH detected +12 and/or 13q14 deletions in six patients with lation by phorbol esters may improve the detection of chromosome anomalies, especially del(13q), in CLL 2,18 and apparently normal karyotype or with no mitosis, with a resultant 76.7% overall incidence of cytogenetic abnormalities. interphase FISH is useful in this disorder, 816, 19 in which in vitro divisions may frequently occur in normal T lymphocytes. 20 A higher incidence of advanced Rai stages (III/IV) was noted in this series as compared with other studies of unselected A preliminary methodological problem in the analysis of the cytogenetic profile of aCLL is represented by the difficulty in CLL, 24 possibly reflecting a more rapid disease evolution in aCLL. No correlation was found, in this (see Table 2 ) and other recognizing 'primary' chromosome changes, due to the complexity of the karyotypes and to the lack of information about studies, 22 between clinical stage and rate of karyotypically abnormal cases. the underlying molecular defects. To be able to analyze the correlation of cytogenetic and clinicobiologic features, we Interestingly, 76% of aCLL were found to have abnormal karyotypes in a recent analysis of 90 cases 10 and a 45% rate subdivided our patients into different groups according to the presence of some recurrent chromosome changes, which of clonal aberrations was detected by Hernandez and coworkers 11 in 157 aCLL, a figure comparing favorably with were present in all abnormal cells in a given patient (see Tables 1-3) . Although these selected abnormalities may 29% abnormal cases in 266 typical CLLs studied at the same institution. potentially represent 'primary' changes, their precise role in the transformation process remains poorly understood.
Our data confirm that +12 is frequently associated with aCLL (15/43 cases) and it is noteworthy that +12, when Our patients denied history of antecedent lymphoproliferative disorder and showed monoclonal CD5 + /CD19 + lymphopresent, was always found in all abnormal metaphase cells. Although the pathogenetic role of +12 in CLL remains elusive, cytosis with the morphologic features of aCLL by FAB criteria. Bone marrow and lymph node histology were consistent with this finding shows that this numerical change may frequently be an early event in the history of the disease. In line with the diagnosis of aCLL, including 19 cases having an atypical immunologic profile, consisting of FMC7 positivity and/or this view, the presence of trisomy 12 as a secondary karyotype anomaly was only rarely documented in two analyses of the bright expression of sIg (see Table 1 ). The CD23 marker was expressed by the majority of our cases and no patient was nature of additional chromosome anomalies in CLL. 25, 26 Unbalanced abnormalities of 6q, leading to loss of genetic found to have a mantle cell phenotype, as defined by the combination of CD5 + /CD19
+ and bright sIg material at bands 6q21-23, were found in all abnormal cells in two patients, one of whom also had +12 in 53% of expression. Thus, the overall surface marker profile in our series is in line with results of previous immunologic studies in interphase cells. In our analysis and in a previous study, 11 the 6q− chromosome frequently occurred as the sole anomaly, aCLL, showing variable proportions of cases with either bright sIg expression and/or FMC7 positivity. 6, 7, 11, 21 
FMC7
suggesting that it may be an important event in the genesis of CLL displaying atypical morphology. The findings by Offit et expression was more frequently found among patients with event, may be regarded as the cytogenetic hallmark of aCLL.
5/67 atypical CLL 39
In conclusion, while confirming the presence of a high inci-
dence of chromosome anomalies, including +12, this study extends our knowledge of the cytogenetic profile of aCLL, showing that: (1) the distinctive cytogenetic feature of aCLL may be represented by karyotypes displaying various combi- where they are almost invariably associated with additional chromosome aberrations; and (4) the sequential development of chromosome aberrations may underlie leukemogenesis in aCLL, and may partially account for the relatively unfavorable al, 27 who described small lymphocytic lymphomas (ie the lymphomatous counterpart of CLL), with del(6)(q21q23), that clinical outcome observed in some cases, requiring early cytotoxic therapy. was associated with circulating prolymphocytes/para immunoblasts in 14 out of 55 cases, support this argument.
Translocations or deletions of 4q and 10q, were found either as the sole anomaly or as part of complex karyotypes
